文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

多粘菌素B血液灌流对严重腹膜炎相关炎症反应的调节作用

Modulation by Polymyxin-B Hemoperfusion of Inflammatory Response Related to Severe Peritonitis.
PubMed 文献 · Shock · 2017-01-01
一句话结论在腹膜炎所致脓毒性休克中,与标准治疗相比,两次多粘菌素B血液灌流未显著改变循环细胞因子水平(IL-17A除外,其临床意义待阐明)。

该研究为随机对照试验ABDOMIX的细胞因子亚组分析,纳入213例腹膜炎所致脓毒性休克患者,比较标准治疗联合2次多粘菌素B血液灌流与标准治疗的差异。69%患者检出革兰阴性菌。两组基线细胞因子无差异;两组TNF-α、IL-1β、IL-10、IL-6、IL-1RA均随时间显著下降;IL-17A仅在灌流组显著下降(P=0.045),对照组无显著变化。第二次灌流结束或对照组对应时间点,两组细胞因子水平无差异;革兰阴性腹膜炎完成两次灌流亚组结果相似。结果不支持多粘菌素B血液灌流对循环细胞因子有显著影响(IL-17A除外)。

要点

  • 纳入213例腹膜炎所致脓毒性休克患者,69%检出革兰阴性菌,随机接受标准治疗联合2次多粘菌素B血液灌流或标准治疗。
  • 两组基线血浆细胞因子浓度无差异,第二次灌流结束或对照组对应时间点两组细胞因子水平仍无差异。
  • 两组TNF-α、IL-1β、IL-10、IL-6、IL-1RA均随时间显著下降(对照组均P<0.0001;灌流组P=0.0002、0.003、<0.0001)。
  • IL-17A仅在多粘菌素B血液灌流组显著下降(P=0.045),对照组无显著变化,其临床意义尚待阐明。
  • 革兰阴性腹膜炎且完成两次灌流亚组结果与总体相似;结果不支持多粘菌素B血液灌流对循环细胞因子有显著影响。

适用人群与场景

  • 腹膜炎所致脓毒性休克患者,纳入随机对照试验ABDOMIX,共213例;69%检出革兰阴性菌。
  • 亚组分析包括革兰阴性腹膜炎且完成两次多粘菌素B血液灌流 session 的患者。

处置流程与药物剂量

  • 标准治疗联合2次多粘菌素B血液灌流 session,与单纯标准治疗对照;具体剂量、血流速、疗程原文未给出。

研究设计与关键结果

  • 随机对照试验ABDOMIX的细胞因子亚组分析,213例腹膜炎所致脓毒性休克患者,比较标准治疗联合2次多粘菌素B血液灌流与标准治疗。
  • 总体人群基线血浆细胞因子浓度两组无差异;第二次灌流结束或对照组对应时间点,两组细胞因子水平无差异。
  • 两组TNF-α、IL-1β、IL-10、IL-6、IL-1RA随时间显著下降:对照组均P<0.0001;灌流组分别为P=0.0002、0.003、<0.0001。
  • IL-17A在多粘菌素B血液灌流组显著下降(P=0.045),对照组无显著变化。
  • 革兰阴性腹膜炎完成两次灌流亚组结果与总体相似。

证据类型、等级与局限

  • 证据类型:随机对照试验ABDOMIX的亚组分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些结果不支持多粘菌素B血液灌流对循环细胞因子有显著影响(IL-17A除外,其临床意义尚待阐明)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Conflicting results have been reported on the influence of Polymyxin-B hemoperfusion treatment on systemic inflammation markers. The aim of the study was to assess in a randomized control trial the influence on plasma cytokine concentrations of Polymyxin-B hemoperfusion in septic shock due to peritonitis. A panel of 10 pro- or anti-inflammatory cytokines was measured in 213 patients with peritonitis-induced septic shock enrolled in the randomized trial ABDOMIX testing the impact of 2 Polymyxin-B hemoperfusion sessions with standard treatment. Gram-negative bacteria were identified in 69% of patients. In the overall population, baseline plasma cytokine concentrations were not different between the two groups. Circulating tumor necrosis factor-α, interleukin (IL)-1β, IL-10, IL-6, and IL-1RA decreased significantly over time in both groups (P <0.0001 for all in controls, and P = 0.0002, 0.003, and <0.0001 in patients treated with Polymyxin-B hemoperfusion). IL-17A decreased significantly in patients treated with Polymyxin B hemoperfusion (P = 0.045) but not in controls. At the end of the second Polymyxin-B hemoperfusion session or at corresponding time in controls, plasma levels of cytokines did not differ between the two groups. Similar results were found in the subgroup of patients with gram-negative peritonitis who completed two Polymyxin-B hemoperfusion sessions. These results do not support a significant influence of Polymyxin-B hemoperfusion on circulating cytokines assessed except for IL-17A which clinical significance remains to be elucidated.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Coudroy R, Payen D, Launey Y, et al. Modulation by Polymyxin-B Hemoperfusion of Inflammatory Response Related to Severe Peritonitis. Shock. 2017. PMID: 27984535

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。